There have been many advances made in the management of patients with liver disease both in diagnosis and in the treatment of underlying liver disease and its complications, although comparatively few of these have been rigorously subjected to full cost-effectiveness evaluation.
In this review, we have analysed a small number of the therapeutic interventions ; while these have been well evaluated clinically, very few have been analysed from the viewpoint of cost-effectiveness and, thus, it is difficult to make many definitive claims.
It is hoped that future studies will consider these aspects as well.
Mots-clés Pascal : Traitement, Analyse coût efficacité, Paracentèse, Cirrhose biliaire, Primitif, Varice, Hémorragie, Hépatite virale, Virose, Infection, Ascite, Abdomen pathologie, Epanchement, Péritonite, Albumine, Article synthèse, Homme, Appareil digestif pathologie, Foie pathologie, Voie biliaire pathologie, Immunopathologie, Maladie autoimmune, Appareil circulatoire pathologie, Vaisseau sanguin pathologie, Veine pathologie, Shunt artérioveineux, Economie santé
Mots-clés Pascal anglais : Treatment, Cost efficiency analysis, Paracentesis, Biliary cirrhosis, Primitive, Varix, Hemorrhage, Viral hepatitis, Viral disease, Infection, Ascites, Abdominal disease, Effusion, Peritonitis, Albumin, Review, Human, Digestive diseases, Hepatic disease, Biliary tract disease, Immunopathology, Autoimmune disease, Cardiovascular disease, Vascular disease, Venous disease, Arteriovenous shunt, Health economy
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 97-0187426
Code Inist : 002B13C03. Création : 21/05/1997.